Metis Global Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-831
| Closed | -$202K | – | 775 |
|
|
2025
Q1 | $202K | Buy |
831
+119
| +17% | +$29K | 0.01% | 731 |
|
|
2024
Q4 | $234K | Buy |
712
+30
| +4% | +$9.86K | 0.01% | 716 |
|
|
2024
Q3 | $228K | Sell |
682
-346
| -34% | -$116K | 0.01% | 712 |
|
|
2024
Q2 | $281K | Sell |
1,028
-20
| -2% | -$5.46K | 0.01% | 661 |
|
|
2024
Q1 | $362K | Buy |
1,048
+14
| +1% | +$4.84K | 0.01% | 626 |
|
|
2023
Q4 | $334K | Sell |
1,034
-48
| -4% | -$15.5K | 0.01% | 633 |
|
|
2023
Q3 | $388K | Buy |
1,082
+103
| +11% | +$36.9K | 0.02% | 583 |
|
|
2023
Q2 | $371K | Buy |
979
+86
| +10% | +$32.6K | 0.02% | 583 |
|
|
2023
Q1 | $428K | Buy |
893
+229
| +34% | +$110K | 0.03% | 516 |
|
|
2022
Q4 | $279K | Buy |
664
+166
| +33% | +$69.8K | 0.02% | 540 |
|
|
2022
Q3 | $208K | Buy |
498
+79
| +19% | +$33K | 0.03% | 496 |
|
|
2022
Q2 | $208K | Buy |
+419
| New | +$208K | 0.03% | 508 |
|